Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapies for treatment resistant cancers. Its approach targets ferroptosis, an anti-cancer mechanism resulting in iron-mediated cancer cell death. Hillstream BioPharma was incorporated in 2017 and is based in Bridgewater, NJ.
Name / Ticker | Price | Zen Rating |
---|---|---|
$3.07 | A | |
$8.24 | A | |
$24.29 | A |